QMSMEDI2024-01-012024-03-31in-bse-fin:OneOperatingExpenses01Member QMSMEDI2024-01-012024-03-31in-bse-fin:FourOperatingExpenses01Member iso4217:INRxbrli:purexbrli:sharesiso4217:INRxbrli:shares QMSMEDI 2023-04-01 2024-03-31 INR Yearly true Cash Flow Indirect Audited Standalone 675251000.00 2593000.00 677844000.00 0.00 510245000.00 -57201000.00 32725000.00 17972000.00 17675000.00 101560000.00 622976000.00 54868000.00 0.00 54868000.00 0.00 54868000.00 15650000.00 -602000.00 15048000.00 39820000.00 0.00 0.00 0.00 39820000.00 39820000.00 178500000.00 10 2.23 2.23 0.00 0.00 0.00 Notes to Standalone Financial Statements 1. The above Audited financial results of the company were reviewed by the Audit Committee & approved by the Board of Directors at its meeting held on Thursday, 23rd May 2024. The auditors have expressed an unmodified opinion on the said financial results. 2. The results of the Company are available for investors at www.qmsmas.com and www.nseindia.com. 3. The figures for the quarter ended 31st March 2024 were prepared by management and were not subject to audit by statutory auditor. 4. The standalone financial results for the quarter ended on 31st March, 2024 have been subjected to Limited Review by statutory auditors of the company and the statutory auditors have issued unmodified report on Audited financial results. 5. The Company is operating as a single segment company, engaged in “Healthcare Equipments and Supplies” and hence there is no separate reportable business segment. 6. As per MCA notification dated 16 February, 2015, companies whose shares are listed on SME exchange as referred to in Chapter XB of SEBI (Issue of capital & Disclosure Requirements) Regulations, 2009 are exempted from compulsory requirement of adoption of IND-AS, as the company is covered under the exempted category, it has not adopted IND-AS for preparation of financial results. 7. There are no Investor complaints pending as on 31st March 2024. 8. Previous year figures have been regrouped/reclassified where required to make them comparable with figures of current period. 9. The Board of directors at its meeting held on May 23, 2024 have recommended a Final dividend of 5% i.e. of Rs. 0.50 per equity share for the Financial Year 2023-2024, subject to shareholder’s approval in the ensuing Annual General Meeting. Half year ended March 31, 2024 Debt Equity Ratio: 0.04 Debt Service Coverage Ratio: 4.78 Interest Service Coverage Ratio: 5.41 Year to date March 31, 2024 Debt Equity Ratio: 0.04 Debt Service Coverage Ratio: 5.59 Interest Service Coverage Ratio: 6.44 Audited Standalone 1221280000.00 4556000.00 1225836000.00 0.00 875774000.00 -76531000.00 55018000.00 31256000.00 34400000.00 183560000.00 1103477000.00 122359000.00 0.00 122359000.00 0.00 122359000.00 33150000.00 -816000.00 32334000.00 90025000.00 0.00 0.00 0.00 900.25 90025000.00 178500000.00 10 606638000.00 5.04 5.04 0.00 0.00 0.00 Other Expenses 101560000.00 Other Expenses 183560000.00 -1842000.00 34400000.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 32558000.00 -76531000.00 -23486000.00 -87946000.00 4416000.00 76610000.00 -311000.00 -107248000.00 -74690000.00 47669000.00 0.00 0.00 0.00 34049000.00 0.00 13620000.00 0.00 0.00 13620000.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 4556000.00 0.00 -32373000.00 0.00 -27817000.00 0.00 0.00 -27817000.00 0.00 0.00 0.00 20000000.00 5222000.00 8925000.00 1764000.00 0.00 0.00 4089000.00 0.00 0.00 4089000.00 -10108000.00 0.00 -10108000.00 12663000.00 2555000.00